You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Accelerated phase chronic myologenic leukemiaall indications
Also known as: Accelerated phase chronic myologenic leukemia / Accelerated phase Chronic myeloid leukemia / Accelerated phase chronic myologenic leukaemia / Myeloid leukemia, chronic / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Chronic myeloid leukemia / CML / Chronic myelogenous leukaemia / Chronic myelocytic leukaemia / Leukemia myelocytic chronic / Chronic myelogenous leukemia / Leukaemia myelocytic chronic / Chronic granulocytic leukemia / Leukaemias chronic myeloid / Chronic myelocytic leukemia / Chronic granulocytic leukaemia / Chronic myeloid leukaemia / Myeloid leukaemia, chronic
|Drug||Drug Name||Drug Description|
|DB08901||Ponatinib||Ponatinib is a novel Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012.|